Physician Perspectives on Reducing Curative Cancer Treatment Intensity for Populations Underrepresented in Clinical Trials

BACKGROUND: Historically, clinical trials involved adding novel agents to standard of care to improve survival. There has been a shift to an individualized approach with testing less intense treatment, particularly in breast cancer where risk of recurrence is low. Little is known about physician per...

Descripción completa

Detalles Bibliográficos
Autores principales: Rocque, Gabrielle B, Andrews, Courtney, Lawhon, Valerie M, Ingram, Stacey A, Frazier, Rachel M, Smith, Mary Lou, Wagner, Lynne I, Zubkoff, Lisa, Wallner, Lauren P, Wolff, Antonio C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Medical Ethics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732232/
https://www.ncbi.nlm.nih.gov/pubmed/36215065
http://dx.doi.org/10.1093/oncolo/oyac191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732232/
https://www.ncbi.nlm.nih.gov/pubmed/36215065
http://dx.doi.org/10.1093/oncolo/oyac191

Ejemplares similares